Glucagonoma-associated neuropsychiatric and affective symptoms: Diagnostic dilemmas raised by paraneoplastic phenomena

Psychosomatics

Volumn 50, Issue 5, 2009, Pages 548-549

  McGevna, Laura ^a   McFadden, David ^a   Ritvo, Jesse ^a   Rabinowitz, Terry ^a  

^a FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; OCTREOTIDE;

ADULT; BIPOLAR DISORDER; CANCER HORMONE THERAPY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; GLUCAGON RELEASE; GLUCAGONOMA; HUMAN; LETTER; NEUROENDOCRINE TUMOR; PANCREAS RESECTION; PSYCHOLOGICAL ASPECT; SPLENECTOMY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

EID: 73249137921     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.50.5.548     Document Type: Letter

References (7)

1. References 1. Becker SW, Kahn D, Rothman S: Cutaneous manifestations of internal malignant tumors. Arch Dermatol Syphilol 1942; 45:1069-1080
2. Wermers RA, Fatourechi V, Wynne AG, et al: The glucagonoma syndrome: clinical and pathologic features in 21 patients. Medicine 1996; 75:53-63
3. Dourakis SP, Alexopoulou A, Georgousi KK, et al: Glucagonoma syndrome: survival 21 years with concurrent liver metastases. Am J Med Sci 2007; 334:225-227
4. Aoki A, Tsukada T, Yasuda H, et al: Multiple endocrine neoplasia type 1 presented with manic-depressive disorder: a case report with an identified MEN1 gene mutation. Jpn J Clin Oncol 1997; 27:419-422
5. Green AI Austin CP: Psychopathology of pancreatic cancer. a psychobiologic probe. Psychosomatics 1993; 34:208-221
6. Jabbour SA, Davidovici BB, Wolf R: Rare syndromes. Clin Dermatol 2006; 24:299-316
7. Kovacs RK, Korom I, Dobozy A, et al: Necrolytic migratory erythema. J Cutan Pathol 2006; 33:242-245